We assessed the immunohistochemical localization of thyroid transcription factor-1 ("F-1) in the lungs of 24 human fetuses (1 1-23 weeks), three infants without pulmonary pathology (36-42 weeks), and 24 infants (2 days-6.5 months) with hyahne membrane disease (HMD) or bronchopulmonary dysplasia (BPD). TTF-1 was detected in fetal lung epithelial cell nuclei by 11 weeks' gestation. Budding tips of terminal airways had prominently labeled nuclei. By 17 weeks, labeling was present in scattered nonciliated columnar and cuboidal cells. Throughout gestation, TlT-1 nuclear staining was prominent in airways abutting pleural, peribronchial, or perivascular connective tissue, being less prominent in centers of lobules. By 23 weeks, many cells in cuboidal
Introduction
The lining of the respiratory tract consists of a continuous layer of epithelial cells distributed in defined patterns in the conducting and gas exchange regions of the lung. An array of cells, including ciliated, goblet, basal, nonciliated respiratory epithelial cells (including Clara cells), and Type I and Type I1 cells in the alveolar region, are derived from common foregut endodermal progenitor cells early in development. Complex temporal, spatial, cell-cell, and humoral interactions contribute to the variety of differentiated cells lining the airways. These distinct morphological characteristics are associated with the expression of a variety of cellular proteins involved in electrolyte transport, host defense, and the function of pulmonary surfactant required for gas exchange. Differentiated functions of respiratory epithelial cells are profoundly influenced by developmental cues and are further modulated by the proliferation and differentiation that occur during branching morphogenesis, growth and differentiation, and repair of the lung after injury. Recent work from this laboratory identified thyroid transcription factor-1 (TTF-1) also termed NKx2.1, a homeodomain containing nuclear transcription protein, as a critical determinant of lung epithelium-specific gene expression (Bruno et al., 1995; Bohinski et al., 1994) . TTF-1 activated the expression of surfactant proteins (SP) A, B, and C and Clara cell-specific protein (CCSP) gene transcription in a respiratory epithelium-specific manner (Bohinski et al., 1994) . TTF-1 enhanced surfactant protein gene transcription by binding to DNA motifs located in the 5' regions of target genes, determining lung epithelium-specific gene expression. Ablation of TTF-1 in transgenic mice causes severe disruption of lung morphogenesis, supporting the concept that TTF-1 is a critical determinant of lung morphogenesis and gene expression (Oguchi and Kimura, 1995) .
TTF-1 is expressed in the developing forebrain, thyroid epithelium, and in defined subsets of respiratory cells in rat (Lazzaro et al., 1991) . Latzaro et al. (1991) demonstrated TTF-1 mRNA during the earliest period of lung bud formation in the rat fetus. In an initial report, "T-1 was detected in respiratory epithelial cells in the developing airway and in the alveoli of human lung (Ikeda et al., 1995) . Because of the important role of TTFl in lung differentiation and gene expression, we have assessed the temporal and spatial distribution of TTF-1 during development of the human fetal and postnatal lung. Because perinatal lung injury is associated with respiratory disease and remodeling of the respiratory tract, the dis-tribution of 'ITF-1 was also assessed in lungs from infants with acute and chronic lung diseases, hyaline membrane disease (HMD) and bronchopulmonary dysplasia (BPD). The distribution of?TF-1 staining is similar to that of CCSP and SP A, B, and C, supporting the potential role of lTF-1 in lung development and recovery after injury.
Materials and Methods
Human Lung Tissue. This study was approved by the Committee for the Protection of Human Subjects-Health Sciences of Vanderbilt University Review Board. Lung tissue was available from 24 fetuses of 11-23 weeks' gestation. from three newborn infants (36-42 weeks' gestation), and from 24 neonates of 2 days-6.5 months who died from pulmonary causes including HMD and BPD. Between 1979 and 1991, tissues were obtained with parental consent at hysterotomy or hysterectomy abortion, at postmortem biopsy, or at autopsy. The source of these tissues from very immature fetuses is no longer available, limiting the numbers at early gestational ages. The distribution of SP-A, SP-B. and SP-C in these samples has been previously reported (Khoor et al., 1993 (Khoor et al., ,1994 Stahlman et al., 1992) . Tissues were fixed in 10% phosphate-buffered formalin, in most cases within 2 hr after death, dehydrated through graded ethanols, and embedded in paraffin. Four-Bm-thick sections were cut and mounted on Superfrost Plus (Fisher, Atlanta, GA) glass slides.
Immunohistochemistry. Tissues were processed, sectioned, deparaffinized, quenched in 0.3% H202 in methanol, and rehydrated as described previously (Stahlman et al., 1992) . Slides were then subjected to a 25-min microwave treatment in a 1 x Antigen Retrieval Citra buffer (BioGenex Laboratories; San Ramon, CA). Immunostaining for m -1 was greatly enhanced by antigen retrieval, perhaps increasing the availability of the antigen. After removal from microwave, slides were allowed to remain in the 1 x Antigen Retrieval Citra buffer for an additional 20 min, after which they were rinsed and placed in PBS. Nonspecific staining was blocked by exposing slides for 30 min to prediluted normal goat serum (BioGenex). The appropriately diluted rabbit anti-m-1 serum (kindly provided by Dr. Roberto DiLauro, Station Zoology Anton Dohra, Naples, Italy) was then applied and incubated for 1-2 hr at room temperature as previously described (Ikeda et al., 1995) . After washing, a biotinylated goat anti-rabbit immunoglobulin reagent was applied to the slides for 30 min (BioGenex SS kit). After washing, a peroxidase-conjugated streptavidin was added and incubated for 30 min. Peroxidase activity was then detected by DAB and counterstained with hematoxylin.
Results

Speczfcity of TTF-1 Staining in Human Thyroid and Lung
TTF1 antibody stained nuclei of epithelial cells from neonatal thyroid gland ( Figure 1 ) and of subsets of epithelial cells in the developing lung. Immunostaining of nuclei with this antibody was not detected in other adult organs tested, including brain, breast, gastrointestinal tract, heart, liver, kidney, and muscle. Preincubation of the primary antibody with recombinant rat TTF-1 protein or substitution with nonimmune rabbit serum completely blocked immunoreactivity in nuclei in histological sections (data not shown).
Immunohistochemical Localization of TTF-1 in Human Fetal Lung
TTF-1-labeled nuclei were not detected in the lung buds of a single %week fetal specimen. TTF-1 was detected in the nuclei of columnar nonciliated epithelial cells of the human fetal lung as early as 11-12 weeks' gestation ( Figures 2 and 3) . By 17 weeks' gestation, additional nuclear labeling was present in scattered nonciliated epithelial cells in both columnar and cuboidal cell-lined airways ( Figure  4 ). By 18 weeks, nuclei of many epithelial cells of the terminal airways were labeled intensely, being most prominent in cells at the tips of developing buds. Between 20 and 22 weeks' gestation, immunolabeled nuclei of TTF-1-staining cells were most prominent in the budding airways at the periphery of the lobule, closely abutting pleural, peribronchial, and perivascular connective tissue ( Figures 5 and 6 ). In contrast, at this time of gestation, staining in nuclei of columnar cells in more proximal airways was sparse or absent (Figure 5 ) . Between 36 and 42 weeks' gestation, mature Type I1 cell nuclei were intensely labeled by the anti-TTF-1 antibody, as were cells lining bronchiolo-alveolar portals (Figures 7 and 8 ). The number of bronchiolar cells immunolabeled for 'MF1 decreased with advancing development, and labeling was not detected in squamous epithelial cells of the alveolus (Type I cells). Sites of expression of TTF-1 in bronchiolo-alveolar regions were consistent, in general, with the overlapping distribution of SP A, B, and C in alveolar portals and alveoli (Table 1) and that of CCSP in bronchioles (Ikeda et al., 1995; Khoor et al., 1993) .
Distribution of TTF-1 in Neonatal Lung Disease
In lungs from patients with HMD and BPD, nuclear labeling of terminal airway cells for TTF-1 was not generalized and was most deficient in areas of hemorrhage or atelectasis. Although TTF1 staining was detected in all samples in the injured lungs, staining was most prominent in nuclei of cells lining expanded terminal airways, labeling being most intense in epithelial cells near pleural surfaces, adjacent to peribronchial and perivascular connective tissue ( Figure 9 ). TTF-1 staining was also observed in nuclei of some bronchiolar cells in these patients. In older patients with longstanding BPD, immunolabeling of nuclei was sparse or absent in collapsed airways, in regions of infection, and in the slit-like airways lined by dysplastic epithelial cells. In contrast, TTF-1 was prominent in nuclei of cells of the open airways and in regions of regeneration ( Figure 10 ). Immunolabeling was prominent in the regenerating tips of terminal airways in a distribution similar to that of SP-C and SP-B mRNA and proteins previously seen in the developing lung (Khoor et al., 1994) .
Discussion
TTF-1 binds to a consensus DNA element, CAAG, present in a number of thyroid and lung epithelial cell-specific genes (Bruno et al., 1995; Bohinski et al., 1994) . Extensive in vitro evidence supports the critical role of 'ITF-1 in the expression of SP-A, SP-B, SP-C, and CCSP. Site-specific mutagenesis of the TTF-1 binding site blocked expression of promoter-reporter constructs transfected into lTF-1 IN FETAL AND NEONATAL HUMAN LUNG pulmonary adenocarcinoma cells (H441-1) and a mouse lung epithelial cell line ( m -1 5 ) (Bruno et al., 1995; Bohinski et al., 1994) .
Transfection of an expression vector directing the synthesis of lTF1
in HeLa cells (cells that do not express surfactant protein) strongly transactivated expression of SP-A, -B, -C, and CCSP. Addition of a TTF-1 consensus binding site from the SP-B gene to SV40 viral promoter element conferred lung epithelial cell specificity to gene expression from the vector (Yan et al., 1995) . ' Igken together, these findings support the role of "F-1 in gene expression in respiratory epithelium.
The synthesis of SP-A, SP-B, and SP-C is generally confined to partially overlapping and distinct subsets of respiratory epithelial cells during lung development, each gene being subjected to unique regulatory influences. For example, in human lung, SP-A is expressed in specific serous cells of tracheal and bronchial glands, in some bronchiolar cells, and in alveolar Type I1 epithelial cells (Khoor et al., 1993). SP-B is found rarely in the developing tracheal or bronchial glands but is expressed in specific bronchiolar lining cells and in Type I1 epithelial cells or their precursors in terminal airways (Stahlman et al., 1992) . In contrast, in the term lung and thereafter, SP-C mRNA and proprotein are confined to Type I1 epithelial cells (Khoor et al., 1994) . The distribution of each gene and the timing of gene expression are similar but distinct during development, and each is uniquely altered by oxygen, glucocorticoids, epidermal growth factor, and other hormones (Kuroki and Voelker, 1994) . Therefore, the distribution of TTEl immunostaining overlaps with the expression of the surfactant proteins. TIT1 is required for the high-level expression of the promoter construct from each of the surfactant proteins and CCSP in vitro: However, the distribution of TTF1 is not sufficient to explain the heterogeneity of ' Stahlman et al., 1992 . Khoor et al., 1993 CCSP promoters in concert with AP1, HNF family members (Clevidence et al., 1994; Bingle and Gitlin, 1993; Sawaya et al., 1993; Stripp et al., 1992) and other nuclear proteins that interact with the promoter elements of these genes, complex interactions of these transcriptional regulatory proteins may provide mechanisms that determine independent regulation of each of the genes. Alternatively, variations in the levels of TTFl in the airway epithelial cells or its posttranscriptional modification, perhaps by oxidation-reduction (Arnone et al., 1995) , may provide the regulatory cells. In the present study, TTF-1 was not detected in Type I epithelial cells or in the ciliated cells in the conducting airways, suggesting that the differentiation of the subsets of cells from earlier progenitor cells is associated with the loss of expression of TTF1, since Type I cells are generated by terminal differentiation from Type I1 cells.
In the term lung, TTF-1 was detected primarily in nuclei of Type I1 epithelial cells and was only rarely seen in distal conducting airway cells. However, TTF1 immunostaining was absent in Type I1 cells in some regions after injury associated with HMD or BPD. 'ITF-1 immunostaining was often absent in regions of acute inflammation, edema, hemorrhage, and atelectasis, but was detected at discrete sites in regenerating cells of the recovering airways and reexpanding alveoli. The pattern of expression of SP-B and SP-C in these pathological conditions was similar to that of 'ITF-1. TTF-1 immunostaining was particularly prominent in regions lined by regenerating cuboidal cells in close apposition to dense stromal or mesenchymal tissues, as seen in the developing lung. Infants with HMD and BPD are treated with high concentrations of oxygen and positive-pressure ventilation, and often have clinical courses complicated by lung inflammation and infection. It is of interest that gene expression of SP-A, SP-B, and SP-C was inhibited by inflammatory cytokines such as tumor necrosis factor-a (TNFa) (Bachurski et al., 1995; Wispe et al., 1990) . Effects of TNFa on SP-C gene transcription are mediated by transcriptional mechanisms dependent on cis-acting elements in the 5' region of the human SP-C gene (Bachurski et al., 1995) . Likewise, a deficiency of SP-A was noted in a primate model of BPD, SP-B and SP-C being most prominently expressed in regenerating epithelial cells (Coalson et al., 1995) , as seen in human infants with BPD (Stahlman et al., 1992) . The loss of TTF1, a gene critical to SP synthesis and gene transcription, may contribute to the lack of adequate surfactant in infants with acute and chronic lung disease. The finding that 'ITF-1 is consistently most abundantly expressed in the tips of lung buds and in regenerating regions in close proximation to lung mesenchyme supports the hypothesis that the epithelium in these regions is S T A H L W , GRAY, WHITSE'IT strongly influenced by mesenchymal signals involved in lung cell regeneration and differentiation. The reappearance of TTF-1 and factors exhibit distinct cellular expression patterns in lung and regulate the surfactant protein promoter. Dev surfactant proteins in regions of regenerating lung supports the possibility that TTF-1 plays a role in epithelial cell growth and differentiation that ultimately may be a critical factor in restoration of alveolar structures that accompanies recovery from neonatal lung diseases. Elucidation of the factors regulating 'ITF1 gene transcription expression and function in the developing and recovering lung may therefore be important to the understanding of the pathogenesis and treatment of acute and chronic lung disease in infants.
